We investigated whether selective inhibition of serotonin (5-hydroxytryptamine; 5-HT) transporter with citalopram leads to accumulation of 5-HT in catecholaminergic neurons. In the rabbit olfactory tubercle, citalopram (1-10 M) inhibited [
3
H]5-HT release, with a greater effect on NE than on DA. These results suggest that in the rabbit olfactory tubercle, where there is coexistence of 5-HT, NE, and DA neurons, inhibition of the 5-HT transporter led to accumulation of 5-HT in catecholaminergic terminals. Thus, during treatment with selective serotonin uptake inhibitors (SSRIs), 5-HT may be stored in catecholaminergic neurons acting as a false neurotransmitter and/or affecting the disposition of DA and/or NE. Transmitter relocation may be involved in the antidepressant action of SSRIs.
Despite their lower affinity for serotonin (5-hydroxytryptamine; 5-HT), there is experimental evidence to suggest that catecholaminergic neurons may take up and store 5-HT. Indeed, 5-HT-immunoreactive fibers in the pars intermedia of the rat pituitary gland can be eliminated by treatment with 6-hydroxydopamine, a neurotoxin selective for catecholamine neurons (Saland et al., 1986) . Interestingly, Thind and coworkers (1987) observed the presence of 5-HT staining in tyrosine hydroxylase-immunoreactive fibers in the suprachiasmatic nuclei and ventromedial hypothalamus 24 h after infundibular stalk section. These authors proposed that catecholaminergic terminals might take up 5-HT coming from cut 5-HT terminals. In a study by Feuerstein and coworkers (1986) , prolonged incubations of caudate nucleus slices with [ 3 H]5-HT led to labeling of catecholaminergic terminals, which was prevented by the NE/DA uptake inhibitor nomifensine but not by the selective 5-HT reuptake inhibitor 6-nitroquipazine. The above observations suggest that storage of 5-HT may occur in catecholamine-containing neurons. Based on the above described findings, we proposed that in brain areas where there is a coexistence of catecholaminergic and serotonergic terminals, 5-HT could accumulate in catecholaminergic neurons if the 5-HT neuronal transporter (neuronal uptake pump) is inhibited with a selective 5-HT transporter inhibitor. To test this hypothesis, we employed the olfactory tubercle of the rabbit because of its high density of 5-HT, DA, and NE terminals (Dahlstrom and Fuxe, 1964; Conzolazione and Cuello, 1982; Fallon and Moore, 1987) . In addition, the olfactory tubercle is a limbic region of easy access and could be a relevant site of action for antidepressant drugs (Rosin et al., 1995) . Citalopram was used as the selective serotonin reuptake inhibitor (SSRI) (Sitte et al., 2000) . The experimental rationale was based on the assumption that incubation with low concentrations of [ 3 H]5-HT results in selective labeling of 5-HT terminals, whereas incubation of [ 3 H]5-HT in the presence of citalopram would favor labeling of catecholaminergic neurons. In addition, based on the higher affinity of the 5-HT terminals for 5-HT, we proposed that nonradioactive 5-HT should be more potent than NE and DA in displacing [
3 H]5-HT, when the [ 3 H]5-HT is stored in serotonergic terminals. Such specificity should be lost if the 5-HT would be stored in catecholaminergic terminals. Our findings suggest that catecholaminergic terminals take up 5-HT when the 5-HT uptake pump is inhibited with the SSRI, citalopram.
Materials and Methods
Male New Zealand rabbits (2-3.5 kg) were sacrificed by decapitation. The brains were quickly removed, and olfactory tubercles were immediately dissected on ice in a cold room at 4°C, following these landmarks: diagonal band of Broca (caudal-medial border), beginning of the olfactory tract (rostral border), lateral olfactory tract (lateral border), and medial forebrain bundle (dorsal border). Next, the tissues were chopped into 0. 3 H]5-HT either in the presence or in the absence of the 5-HT-uptake pump inhibitor citalopram (1 or 10 M) and/or the NE/DA uptake pump inhibitor nomifensine (1 or 10 M). Subsequently, the slices were washed three times with 4 ml of cold (4°C) superfusion medium, and the radioactivity present in the slices was quantified by liquid scintillation spectrometry.
Displacement of Stored [
3 H]5-HT. Immediately after incubation, two olfactory tubercle slices were transferred to a nylon mesh mounted on a polypropylene cylinder. The cylinders were then placed in 1-ml glass superfusion chambers. The slices were superfused with prewarmed oxygenated superfusion medium (37°C) at 1 ml/min. Fraction collection (5-min fractions) started after a 75-min washout period with drug-free medium. After obtaining a basal efflux of radioactivity for 20 min, slices were superfused with stepwise increasing concentrations (from 1 nM to 30 M) of either 5-HT, DA, or NE at sequential intervals of 20 min. In a group of experiments, the effects of 5-HT, NE, or DA were studied in the presence of either 1 M citalopram or 1 M nomifensine. In these experiments, perfusion with citalopram or nomifensine started 30 min before collection of baseline samples (50 min before perfusion with monoamines) and continued until the end of the experiment. Radioactivity in the superfusate-fractions (efflux) and in the slices (at the end of the experiment) was quantified by liquid scintillation spectrometry. Because of differences in the extent of labeling observed between control slices and those labeled in the presence of citalopram, the efflux results were always corrected by the amount of radioactivity present in the slices. The efflux results were expressed as fractional release, i.e., as a percentage of the tissue 3 H content. The radioactivity (total 3 H) collected in the superfusion samples consisted of a mixture of unchanged [
3 H]5-HT and their respective 3 H-metabolites (Fozard and Berry, 1976) . In this study, for convenience, the collected 3 H]5-HT was expressed in absolute values (dpm/5 min) and as a fraction of the amount of radioactivity present in the tissue (slices) at the time of sample collection. One-way analysis of variance (ANOVA) was used to establish overall effect of uptake pump inhibitors on uptake of [ 3 H]5-HT, using different treatments (concentrations and combinations) as the levels. Repeated measurement one-way ANOVA was used to determine overall ability of increasing concentrations of nonradioactive monoamines to displace [ 3 H]5-HT, serving monoamine concentrations as a repeated factor. Two-way ANOVA for a repeated measurement design was used to determined differences in [ 3 H]5-HT displacement induced by nonradioactive monoamines in the presence or absence of uptake pump inhibitors, with uptake condition (with or without inhibition) as the cross-factor and monoamine concentrations as the repeated measure factor. In cases where the two-way ANOVA revealed significant interaction between the two factors, data were again analyzed with repeated measurement one-way ANOVA. Statistically significant effects detected by ANOVA were further analyzed using Duncan's multiple range test. Significance was assumed at P Ͻ 0.05.
Results

Effect of Citalopram and Nomifensine on [
3 H]5-HT Uptake. In slices of the olfactory tubercle, the SSRI citalopram (1-10 M) inhibited the uptake of 0.1 M [ 3 H]5-HT to a maximum of 71 Ϯ 2% (Table 1) . Comparable degrees of uptake inhibition were observed with 1 and 10 M citalopram (Table 1) (Fig. 1) . Nearly 8% (7.8 Ϯ 0.5%) of tissue radioactivity was released by 0.1 M 5-HT, and radioactivity increased to 34 Ϯ 2% with 1 M 5-HT (Fig. 1A) . Neither DA nor NE at low concentrations (0.03-1 M) evoked the release of [ 3 H]5-HT (Fig. 1A ). The increase in 3 H efflux induced by 5-HT was greatly antagonized by coperfusion with 1 M citalopram (P ϭ 0.0001) (Fig. 2) . These results suggest that when the olfactory tubercle slices are incubated with (Fig. 3) . Indeed, in control slices, 0.1 M 5-HT released 7.8 Ϯ 0.5% and 1.0 M released 34 Ϯ 2% of tissue radioactivity. In slices labeled in the presence of citalopram, 0.1 M 5-HT failed to evoke release, and 1.0 M released only 5.5 Ϯ 0.6% of tissue radioactivity (P Ͻ 0.001) (compare Fig. 1, A and B) .
In slices labeled in the presence of citalopram, superfusion with NE or DA at concentrations as low as 0.3 and 1 M evoked significant increases in the release of [ 3 H]5-HT (Fig.  1B) . However, in control experiments (labeling without citalopram), 1 and 3 M DA and NE failed to evoke the release of [
3 H]5-HT (Fig. 1A) . In addition, in slices labeled in the presence of citalopram, when citalopram was coperfused with DA or NE, it potentiated the releasing effects of both catecholamines (Fig. 3) . Both DA and NE (3-10 M) evoked a much greater release of [ 3 H]5-HT when perfused in the presence of citalopram (P ϭ 0.0001) (Fig. 3) . On the other hand, when citalopram was coperfused with 5-HT, it induced a very small parallel shift to the right in the concentration-release curve for 5-HT (P ϭ 0.0593) (Fig. 3) .
In slices labeled in the presence of citalopram, nomifensine reduced NE, DA, and 5-HT-evoked release of [ 3 H]5-HT (Fig.  4) . Nomifensine antagonized the releasing effect of NE to a greater extent than that of DA (Fig. 4) . Although for both catecholamines, nomifensine seemed to induced a parallel shift to the right, the release evoked by 5-HT was decreased, but only at the highest concentrations, 3 to 10 M (P ϭ 0.0006) (Fig. 4) .
Discussion
Incubation of control rabbit olfactory tubercle slices with concentrations of [ 3 H]5-HT (0.1 M) close to the K m for the neuronal uptake (60 -180 nM) (Richelson and Pfenning, 1984; O'Reilly and Reith, 1988) , led to selective labeling of 5-HT terminals. This statement is based on the following experimental facts (present study): 1) only submicromolar concentrations of 5-HT, but not DA or NE, displaced radioactivity from slices preloaded with Immediately after incubation, the slices were extensively washed with superfusion medium (37°C) and placed on superfusion chambers. Superfusion rate was 1 ml/min. Fraction collection (5-min fractions) started after a 75-min washout period with drug-free medium. After obtaining a basal efflux of radioactivity for 20 min, slices were superfused with stepwise increasing concentrations (20 min each) of 5-HT (controls). In another set of experiments, the releasing effects of 5-HT were evaluated in the presence of 1 M citalopram. In these experiments, citalopram was added to the superfusion medium 30 min prior to initiating the superfusion with 5-HT. Ordinate, increase in [ 3 H]5-HT efflux induced by 5-HT expressed as a percentage of tissue radioactivity. Abscissa, log molar concentration of 5-HT. Release in the presence of citalopram was significantly different from in controls. Significantly different from controls at ૺ, P Ͻ 0.01; ૺૺ, P Ͻ 0.001. inhibitor) had negligible (10 -15%) effects in inhibiting 5-HT uptake. Our conclusion is based on the specificity of the drugs employed and on the premise that 5-HT and catecholamine neuronal pumps do not take up 5-HT metabolites (Caccia et al., 1992; Manfridi et al., 1992; Wong et al., 1995) . Thus, the tissue labeling and the displacement of 3 H from the slices most likely derive from unchanged [ 3 H]5-HT. The concentration of 1 M citalopram employed in this study is 1000-fold higher than its K i for 5-HT uptake, and 4 and 28 times lower than its K i for NE and DA uptake, respectively (Richelson and Pfenning, 1984; Sitte et al., 2000) , indicating that citalopram is selective for the 5-HT transporter. Consequently, 1 M citalopram should have blocked 5-HT uptake with negligible effects on neuronal catecholamine transporters. Nomifensine, on the other hand, selectively inhibits NE and DA transporters. Its small inhibitory effect on [ 3 H]5-HT accumulation may result from a slight effect on 5-HT transport, since nomifensine K i for 5-HT uptake is about 1.2 M (Richelson and Pfenning, 1984) .
A striking finding of this study was the inability of high micromolar concentrations of citalopram to produce a complete block of [ 3 H]5-HT uptake. Olfactory tubercle slices incubated in the presence of concentrations of citalopram as high as 10 M could still take up and retain considerable amounts of [ 3 H]5-HT (30 -40% of the amount of radioactivity taken up by control slices). The concentration of citalopram used should have been sufficient to block completely the neuronal 5-HT transporter, since it was 5,000-to 10,000-fold higher than the K i for the 5-HT uptake (Richelson and Pfenning, 1984; O'Reilly and Reith, 1988 Immediately after incubation, the slices were extensively washed with superfusion medium (37°C) and placed on superfusion chambers. Superfusion rate was 1 ml/min. Fraction collection (5-min fractions) started after a 75-min washout period with drug-free medium. After obtaining a basal efflux of radioactivity for 20 min, slices were superfused with stepwise increasing concentrations (20 min each) of either DA, NE, or 5-HT. In another set of experiments, the releasing effects of DA, NE, and 5-HT were evaluated in the presence of 1 M citalopram, which was added to the superfusion medium 30 min before initiating the superfusion with DA, NE, or 5-HT. Ordinates, increase in [ 3 H]5-HT efflux induced by DA, NE, or 5-HT expressed as a percentage of tissue radioactivity. Abscissa, log molar concentration of DA, NE, or 5-HT. Significantly different from experiments in the absence of citalopram at ૺ, P Ͻ 0.01; ૺૺ, P Ͻ 0.001. Immediately after incubation, the slices were extensively washed with superfusion medium (37°C) and placed on superfusion chambers. Superfusion rate was 1 ml/min. Fraction collection (5-min fractions) started after a 75-min washout period with drug-free medium. After obtaining a basal efflux of radioactivity for 20 min, slices were superfused with stepwise increasing concentrations (20 min each) of either DA, NE, or 5-HT. In another set of experiments, the releasing effects of DA, NE, and 5-HT were evaluated in the presence of 1 M nomifensine, which was added to the superfusion medium 30 min before initiating the superfusion with DA, NE, or 5-HT. Ordinates, increase in [ 3 H]5-HT efflux induced by DA, NE, or 5-HT expressed as a percentage of tissue radioactivity. Abscissa, log molar concentration of DA, NE, or 5-HT. Significantly different from experiments in the absence of nomifensine at ૺ, P Ͻ 0.01; ૺૺ, P Ͻ 0.001.
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